Union Budget 2026: Bio Pharma Shakti to Drive Domestic Biopharma Growth
Finance Minister Nirmala Sitharaman unveiled the Bio Pharma Shakti programme during the Union Budget 2026-27 presentation, allocating Rs 10,000 crore over five years to boost India’s biopharmaceutical and biosimilars ecosystem. The initiative aims to strengthen manufacturing, innovation, and global competitiveness in strategic and frontier sectors. It will also support the development of city economic regions, promoting industrial clusters and attracting long-term investment.
Union Budget 2026: Economic Stability and Fiscal Discipline at the Core
Addressing Parliament, Sitharaman highlighted India’s economic trajectory since the Modi government took office, citing stability, fiscal discipline, sustained growth, and moderate inflation. She emphasized the government’s focus on Atmanirbharta (self-reliance) while balancing ambition with inclusion. Presenting her ninth consecutive Budget, the Finance Minister underscored reforms, strategic action, and equitable growth across all regions and sectors.
Union Budget 2026: Growth and Inflation Outlook Reflect Positive Momentum
Ahead of the Budget, the Economic Survey 2025-26 outlined India’s economic performance over the past year. Real GDP growth for 2026-27 is projected at 6.8–7.2%, reflecting medium-term resilience amid global challenges. Inflation remains low, with April–December 2025 average CPI inflation at 1.7%, driven by disinflationary trends in food and fuel prices. Favorable supply-side conditions and GST rationalization are expected to support a benign inflation outlook going forward.
With initiatives like Bio Pharma Shakti, fiscal discipline, and strategic growth planning, India aims to strengthen domestic industries, attract global investments, and maintain a resilient economy capable of meeting future challenges.
(This article has been syndicated from ANI)
Aishwarya is a journalism graduate with over three years of experience thriving in the buzzing corporate media world. She’s got a knack for decoding business news, tracking the twists and turns of the stock market, covering the masala of the entertainment world, and sometimes her stories come with just the right sprinkle of political commentary. She has worked with several organizations, interned at ZEE and gained professional skills at TV9 and News24, And now is learning and writing at NewsX, she’s no stranger to the newsroom hustle. Her storytelling style is fast-paced, creative, and perfectly tailored to connect with both the platform and its audience. Moto: Approaching every story from the reader’s point of view, backing up her insights with solid facts.
Always bold with her opinions, she also never misses the chance to weave in expert voices, keeping things balanced and insightful. In short, Aishwarya brings a fresh, sharp, and fact-driven voice to every story she touches.
